tiprankstipranks
Agios Pharma: Promising Growth with Strategic Market Expansion and Pipeline Advancements
PremiumRatingsAgios Pharma: Promising Growth with Strategic Market Expansion and Pipeline Advancements
2M ago
Agios Pharmaceuticals reports Q4 revenue $10.7M, consensus $9.35M
Premium
The Fly
Agios Pharmaceuticals reports Q4 revenue $10.7M, consensus $9.35M
2M ago
Agios Pharmaceuticals reports results from Phase 3 ACTIVATE-Kids study
Premium
The Fly
Agios Pharmaceuticals reports results from Phase 3 ACTIVATE-Kids study
2M ago
Agios Pharmaceuticals announces key 2025 milestones, catalysts through 2026
PremiumThe FlyAgios Pharmaceuticals announces key 2025 milestones, catalysts through 2026
3M ago
Agios Pharmaceuticals announces FDA accepted sNDA for PYRUKYND
Premium
The Fly
Agios Pharmaceuticals announces FDA accepted sNDA for PYRUKYND
3M ago
Agios Pharmaceuticals price target lowered to $55 from $60 at BofA
Premium
The Fly
Agios Pharmaceuticals price target lowered to $55 from $60 at BofA
3M ago
Agios presents results from Phase 3 ENERGIZE-T Study of Mitapivat
PremiumThe FlyAgios presents results from Phase 3 ENERGIZE-T Study of Mitapivat
4M ago
Agios Pharmaceuticals to present new data on mitapivat, tebapivat
Premium
The Fly
Agios Pharmaceuticals to present new data on mitapivat, tebapivat
5M ago
Agios Pharmaceuticals price target raised to $53 from $51 at Scotiabank
Premium
The Fly
Agios Pharmaceuticals price target raised to $53 from $51 at Scotiabank
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100